1 Introduction Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide [1], with curative-intent treatment largely restricted to individuals diagnosed at an early stage [2]. International guidelines, therefore, recommend surveillance for individuals living with cirrhosis who are potential candidates for treatment with curative intent, including selected individuals with decompensated cirrhosis who are eligible for liver transplantation [3-5].